On Friday, U.S. Silica Holdings Inc (NYSE:SLCA)’s shares declined -7.64% to $21.28.
U.S. Silica Holdings Inc (SLCA) released its 2014 Sustainability Report, Intersections, detailing the accomplishments over the past year that contributed to the Company’s success in reaching key targets in safety, environmental protection and community support.
The fifth annual Sustainability Report details how the Company’s sustainability efforts intersect with every facet of its business, counting U.S. Silica’s commitment to community investment, employee safety and environmental stewardship. U.S. Silica reached noteworthy milestones in 2014, cementing its status as an industry leader while paving the way for continued innovation and success.
U.S. Silica Holdings, Inc. produces and sells commercial silica in the United States. It operates through two segments, Oil & Gas Proppants, and Industrial & Specialty Products. The company offers whole grain commercial silica products to be used as fracturing sand in connection with oil and natural gas recovery, in addition to sells its whole grain silica products in various size distributions, grain shapes, and chemical purity levels for manufacturing glass products.
Capstone Turbine Corporation (NASDAQ:CPST)’s shares dropped -1.19% to $0.340.
Capstone Turbine Corporation (CPST), the world’s leading clean technology manufacturer of microturbine energy systems, will release financial results for the first quarter of fiscal year 2016 ended June 30, 2015 at 1:45 p.m. Pacific Time (4:45 p.m. Eastern) on August 6, 2015.
Capstone Turbine Corporation develops, manufactures, markets, and services microturbine technology solutions for use in stationary distributed power generation applications worldwide. It offers microturbine units, subassemblies, components, and various accessories for applications, counting cogeneration comprising combined heat and power (CHP) and integrated CHP, in addition to combined cooling, heat, and power; and renewable energy, natural resources, and critical power supply.
At the end of Friday’s trade, Service Corporation International (NYSE:SCI)‘s shares dipped -0.61% to $29.33.
Service Corporation International (SCI) North America’s largest provider of funeral and cemetery services is ongoing to strengthen its philanthropic ties with the American Diabetes Association (ADA) in its hometown, Houston, Texas. SCI, through its brand, “Dignity Memorial”, is proud to declare its title sponsorship for the seventh straight year of the ADA Dignity Memorial Tour de Cure Houston.
Since partnering with the ADA, SCI has contributed over $4.5 million to fund critical diabetes research, education and advocacy programs to support children and adults living with diabetes.
The annual cycling event will take place on Sept. 26, 2015. Registration is now open on the ADA Dignity Memorial Tour de Cure website, where participants can sign up to ride as individual or as a part of a team. The Tour is open to everyone, and offers routes for the novice and expert cyclists.
Service Corporation International, together with its auxiliaries, provides deathcare products and services in the United States and Canada. The company operates through Funeral and Cemetery segments. Its funeral service and cemetery operations comprise funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and related businesses.
Medivation Inc (NASDAQ:MDVN), ended its Friday’s trading session with -5.28% loss, and closed at $102.78.
Medivation, Inc. ( MDVN) declared that it will host a live teleconference with administration to talk about second quarter 2015 financial results and provide a general business update on August 6, 2015 at 4:30 p.m. Eastern Time. A press release for the second quarter of 2015 will be released after markets close on August 6, 2015.
Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
